NCT05949333View on ClinicalTrials.gov

Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

July 31, 2025

Conditions
Breast Neoplasms
Interventions
DRUG

Eflapegrastim

long-acting granulocyte-colony stimulating factor

Trial Locations (1)

Unknown

RECRUITING

Good Gang-An Hospital, Busan

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical Company Limited

INDUSTRY

lead

Eunseong Medical Foundation Good GANG-AN HOSPITAL

OTHER